In this week’s episode, host Mike Moore talks with Meet Vora and Rajatesh Gudibande, co-founders of GraphWear Technologies Inc., about their innovative creation—a needle-free continuous glucose monitoring device aimed at enhancing the management of diabetes that is poised to revolutionize both the technology and healthcare sectors.GraphWear Technologies Inc. is a San Francisco-based technology company that was founded in 2015 and revolutionizes chronic condition management with needle-free, continuous glucose monitoring technology. Their mission is global accessibility, mitigating pain and costs associated with traditional treatments. Working tirelessly to make wearable devices available to all in need.Today, Mike, Meet, and Rajatesh talk about the creation of a glucose monitoring device without needles. They discuss the size of the diabetes market and the challenges faced while developing the technology. They also explore how Apple entering the market could have an impact, and why it's important to have a strong company culture.Notable Quotes“Insulin has been the biggest contributor towards lack of management because insulin is one molecule which can control and that has been misused, I would say, a lot by different companies, of course, to make profits which I don't blame them for, but when it was invented, it was made towards the time it was signed up for a dollar, almost like the people's use and then unfortunately, people don't have access to that molecule that was so cheap to make.” - Rajatesh (08:38) “A company as big as Apple if they are making strides in this industry, it's only going to help everyone because they're going to educate everyone on the importance of why glucose monitoring is important and we in this community, I don't think any one of us look at that as a threat, but rather we are also having to help the diabetic community.” - Meet (15:03) In This Episode(01:25) The origin story: personal experiences that led to the creation of GraphWear(06:50) How type 2 diabetes patients develop a resistance to insulin(07:57) The diabetes epidemic in the market and insulin access issues(09:57) Introduction to the needle-free continuous glucose monitoring technology(11:23) Challenges of needle-free glucose monitoring(15:01) The impact of Apple's entry into the digital health space(15:41) Apple's long-standing development of non-invasive glucose monitoring technology(17:32) GraphWear's specificity factor in glucose monitoring(18:33) The current stage of development and regulatory process for the needle-free continuous glucose monitoring technology(20:30) Opportunity in elite performance management(21:22) GraphWear's culture and first principles of thinking(25:44) Importance of self-policing in high-performing teamsOur GuestsRajatesh Gudibande, Co-Founder and CEO of GraphWear, holds a Bachelor's in electrical and electronics engineering from Jawaharlal Nehru Technological University and a Master's in nanotechnology from the University of Pennsylvania. He pioneers non-invasive glucose monitoring, championing accessible healthcare solutions with $20.5M in funding.Meet Vora is the Director of Operations & Founding member at GraphWear Technologies Inc. With extensive work experience since 2012, he has excelled in various roles, including Chemistry Lab Intern, Graduate Advisor, Co-Founder & CTO, and Regulatory Affairs Analyst. Meet holds a B. Tech. in Chemical Engineering, an MSE in Nanotechnology, and multiple entrepreneurship certificates.
Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health